Tradename | Company | Number | Date | Products |
---|---|---|---|---|
INDERIDE LA 80/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
INDERIDE LA 120/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
INDERIDE LA 160/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
INDERIDE-40/25 | WYETH PHARMS INC | N-018031 DISCN | 1982-01-01 | 1 products, RLD |
INDERIDE-80/25 | WYETH PHARMS INC | N-018031 DISCN | 1982-01-01 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
INDERAL LA | ANI PHARMS | N-018553 RX | 1983-04-19 | 4 products, RLD |
INNOPRAN XL | ANI PHARMS | N-021438 RX | 2003-03-12 | 2 products, RLD, RS |
HEMANGEOL | Laboratoires Pierre Fabre | N-205410 RX | 2014-03-14 | 1 products, RLD, RS |
Code | Description |
---|---|
J1800 | Injection, propranolol hcl, up to 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | 1 | 4 | 11 | 10 | 14 | 36 |
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | 4 | 13 | 5 | 6 | 3 | 28 |
Portal hypertension | D006975 | EFO_0000666 | K76.6 | 1 | 2 | 6 | 2 | 12 | 21 |
Esophageal and gastric varices | D004932 | EFO_0009545 | I85 | 1 | — | 4 | 6 | 5 | 16 |
Migraine disorders | D008881 | EFO_0003821 | G43 | — | 1 | 2 | 4 | 4 | 11 |
Hemangioma | D006391 | — | D18.0 | 1 | 4 | 2 | 1 | 4 | 11 |
Traumatic brain injuries | D000070642 | — | S06 | 2 | 3 | 1 | 3 | — | 8 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | 2 | 5 | — | 7 |
Hypertension | D006973 | EFO_0000537 | I10 | — | 1 | 1 | 1 | 3 | 5 |
Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | 1 | 1 | — | 1 | 2 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 11 | 3 | 1 | — | 4 | 18 |
Retinopathy of prematurity | D012178 | EFO_1001158 | H35.1 | 1 | 6 | 1 | — | 1 | 7 |
Burns | D002056 | — | T30.0 | — | 6 | 5 | — | 1 | 7 |
Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | 1 | — | 3 | 4 |
Migraine without aura | D020326 | EFO_0005296 | G43.0 | — | 1 | 2 | — | 1 | 3 |
Melanoma | D008545 | — | — | 1 | 2 | 1 | — | — | 3 |
Supraventricular tachycardia | D013617 | HP_0004755 | I47.1 | — | — | 1 | — | 2 | 3 |
Adjustment disorders | D000275 | — | F43.2 | — | 3 | 1 | — | — | 3 |
Trauma and stressor related disorders | D000068099 | — | F43.9 | — | 3 | 1 | — | — | 3 |
Covid-19 | D000086382 | — | U07.1 | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cocaine-related disorders | D019970 | — | F14 | 2 | 4 | — | — | 1 | 7 |
Orthostatic intolerance | D054971 | — | — | 2 | 1 | — | — | 1 | 3 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 2 | — | — | — | 3 |
Cavernous hemangioma central nervous system | D020786 | EFO_1001343 | — | 1 | 2 | — | — | — | 3 |
Prostatic neoplasms | D011471 | — | C61 | — | 3 | — | — | — | 3 |
Traumatic stress disorders acute | D040701 | EFO_0005223 | F43.0 | — | 3 | — | — | — | 3 |
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 1 | 2 | — | — | — | 3 |
Multiple myeloma | D009101 | — | C90.0 | — | 2 | — | — | 1 | 3 |
Tachycardia | D013610 | HP_0001649 | R00.0 | 1 | 1 | — | — | 1 | 2 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | 1 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 2 | — | — | — | 1 | 3 |
Ovarian epithelial carcinoma | D000077216 | — | — | 2 | — | — | — | 1 | 3 |
Fallopian tube neoplasms | D005185 | — | — | 2 | — | — | — | 1 | 3 |
Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | 1 | 2 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | 1 | 2 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | — | — | — | — | 1 |
Stem cell transplantation | D033581 | — | — | 1 | — | — | — | — | 1 |
Hypoglycemia | D007003 | HP_0001943 | E16.2 | 1 | — | — | — | — | 1 |
Prediabetic state | D011236 | EFO_1001121 | R73.03 | 1 | — | — | — | — | 1 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | — | — | 4 | 4 |
Fibrosis | D005355 | — | — | — | — | — | — | 3 | 3 |
Autistic disorder | D001321 | HP_0000717 | F84.0 | — | — | — | — | 2 | 2 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
Drug interactions | D004347 | — | — | — | — | — | — | 1 | 1 |
Insulin resistance | D007333 | HP_0000855 | E88.819 | — | — | — | — | 1 | 1 |
Orthodontic extrusion | D050793 | — | — | — | — | — | — | 1 | 1 |
Exercise test | D005080 | EFO_0004328 | — | — | — | — | — | 1 | 1 |
Transjugular intrahepatic portasystemic shunt | D019168 | — | — | — | — | — | — | 1 | 1 |
Uterine cervical neoplasms | D002583 | HP_0030159 | — | — | — | — | — | 1 | 1 |
Drug common name | Propranolol |
INN | propranolol |
Description | Propranolol is a propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3. It has a role as a beta-adrenergic antagonist, an anxiolytic drug, an anti-arrhythmia drug, a vasodilator agent, an antihypertensive agent, a xenobiotic, an environmental contaminant and a human blood serum metabolite. It is a secondary amine, a propanolamine and a member of naphthalenes. It is functionally related to a 1-naphthol. |
Classification | Small molecule |
Drug class | beta-blockers (propranolol type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)NCC(O)COc1cccc2ccccc12 |
PDB | — |
CAS-ID | 525-66-6 |
RxCUI | — |
ChEMBL ID | CHEMBL27 |
ChEBI ID | 8499 |
PubChem CID | 4946 |
DrugBank | DB00571 |
UNII ID | 9Y8NXQ24VQ (ChemIDplus, GSRS) |